Nutraceuticals and Gut Health May Prevent Age-Related Cognitive Decline

As global populations age, cognitive decline and neurodegenerative diseases like Alzheimer's present mounting public health challenges. Current treatments only manage symptoms rather than addressing root causes, creating urgent need for preventive strategies.

This narrative review analyzed scientific literature from 2010-2025 across PubMed, Scopus, and Web of Science databases to evaluate how nutraceuticals and gut microbiome interventions might prevent cognitive decline through the microbiota-gut-brain axis.

The analysis revealed that specific nutraceuticals including vitamins, omega-3 fatty acids, coenzyme Q10, polyphenols, and isothiocyanates demonstrate neuroprotective properties. These compounds work through multiple mechanisms: reducing oxidative stress, controlling neuroinflammation, and supporting mitochondrial function. Importantly, the gut microbiota significantly influences how well the body absorbs and utilizes these protective compounds.

Microbiome-targeted interventions showed particular promise. Prebiotics, probiotics, and fecal microbiota transplantation can modulate inflammatory responses in the brain and support cognitive function through the gut-brain connection. This suggests that optimizing gut health may be as important as taking specific supplements for brain protection.

These findings have significant implications for healthy aging strategies. Unlike pharmaceutical approaches that treat disease after onset, nutraceutical and microbiome interventions offer low-risk prevention methods that could be implemented years before cognitive symptoms appear. The research suggests personalized approaches based on individual microbiome profiles may maximize effectiveness, potentially revolutionizing how we approach brain health optimization throughout the lifespan.